World J Urol. 2024 Nov 4;42(1):621. doi: 10.1007/s00345-024-05304-7.
NO ABSTRACT
PMID:39495377 | DOI:10.1007/s00345-024-05304-7
Categories
Reply to Letter to the Editor about “Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis” by Qiang et al
